Abstract

Introduction: Intracerebral hemorrhage (ICH) has high morbidity and mortality without available targets for intervention. Polyamines are metabolites implicated in neurological diseases such as traumatic brain injury, Alzheimer’s Disease, and ischemic stroke. No studies have evaluated polyamines as they relate to ICH occurrence or outcomes. In this pilot study, we sought preliminary data on whether polyamines could be potential novel targets to improve outcomes after ICH. Methods: We analyzed plasma samples from 7 ICH cases and 10 control participants from the Genetics and Environmental Risk Factors for Stroke (GERFHS) IV study for polyamine measurements using Capillary Electrophoresis with Laser Induced Fluorescence Detection with the modality of Micellar Electrokinetic Chromatography. Plasma samples were deproteinized and derivatized with Fluorescein Isothiocyanate. Samples were spiked with standard solutions and compared with standard curves developed per each polyamine. We report median age and sex of the cohort. Peak spermine, spermidine and putrescine levels were compared using a student’s t-test. Results: In this pilot study of participants enrolled into GERFHS IV (median age 67 vs 61, cases vs controls respectively, 50% female) all three unacetylated polyamine levels were higher in cases. Although sample size is modest, there was a trend towards increased spermidine levels with higher mRS at 90 days (r 2 = 0.3342) (Figure 1). Conclusions: For the first time, we have shown that polyamines are elevated after ICH, and that higher polyamine levels may be associated with worse outcomes. This preliminary data supports further evaluation of polyamines as potential targets to improve outcomes after ICH in a larger cohort.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call